Cargando…

Targeting Interleukin 13 for the Treatment of Atopic Dermatitis

Atopic dermatitis (AD) is a common chronic inflammatory skin condition that has a significant impact on a patient’s quality of life and requires ongoing management. Conventional topical and systemic therapies do not target specific components of AD pathogenesis and, therefore, have limited efficacy...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lytvyn, Yuliya, Gooderham, Melinda
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9966769/ https://www.ncbi.nlm.nih.gov/pubmed/36839890 http://dx.doi.org/10.3390/pharmaceutics15020568

Ejemplares similares

Dupilumab: an evidence-based review of its potential in the treatment of atopic dermatitis
por: Eshtiaghi, Panteha, et al.
Publicado: (2018)

Emerging systemic JAK inhibitors in the treatment of atopic dermatitis: a review of abrocitinib, baricitinib, and upadacitinib
por: Nezamololama, Novin, et al.
Publicado: (2020)

Efficacy and Safety of Upadacitinib for Management of Moderate-to-Severe Atopic Dermatitis: An Evidence-Based Review
por: Lytvyn, Yuliya, et al.
Publicado: (2022)

Immunopathogenesis of Atopic Dermatitis: Focus on Interleukins as Disease Drivers and Therapeutic Targets for Novel Treatments
por: Makowska, Karolina, et al.
Publicado: (2023)

Selective IL-13 inhibitors for the treatment of atopic dermatitis
por: Gonçalves, Francisca, et al.
Publicado: (2021)

The hidden sentinel of the skin: An overview on the role of interleukin-13 in atopic dermatitis
por: Napolitano, Maddalena, et al.
Publicado: (2023)

Novel Therapeutic Targets for the Treatment of Atopic Dermatitis
por: Tsuji, Gaku, et al.
Publicado: (2023)

Targeting IL-4 for the Treatment of Atopic Dermatitis
por: Chiricozzi, Andrea, et al.
Publicado: (2020)

The IL-4/-13 Axis and Its Blocking in the Treatment of Atopic Dermatitis
por: Pappa, Georgia, et al.
Publicado: (2022)

Practical Management of Patients with Atopic Dermatitis on Dupilumab
por: Papp, Kim A., et al.
Publicado: (2021)

Difamilast for the treatment of atopic dermatitis
por: Freitas, Egídio, et al.
Publicado: (2023)

Biological Treatments in Atopic Dermatitis
por: Montes-Torres, Andrea, et al.
Publicado: (2015)

Abrocitinib 100 mg Once Daily for Moderate-to-Severe Atopic Dermatitis: A Review of Efficacy and Safety, and Expert Opinion on Use in Clinical Practice
por: Gooderham, Melinda J., et al.
Publicado: (2023)

Atopic dermatitis
por: Watson, Wade, et al.
Publicado: (2011)

Atopic dermatitis
por: Kapur, Sandeep, et al.
Publicado: (2018)

Atopic dermatitis
por: Galli, Elena, et al.
Publicado: (2020)

Association of reduced count of interleukin-13-producing cells in breast milk with atopic dermatitis in infancy
por: Moradkhani, Sepideh, et al.
Publicado: (2018)

Atopic dermatitis: allergic dermatitis or neuroimmune dermatitis?
por: Gaspar, Neide Kalil, et al.
Publicado: (2016)

Dual Interleukin-4/Interleukin-13 Blocker-induced Arthralgia Treated Successfully with Upadacitinib in a Patient with Atopic Dermatitis
por: TANJI, Takayuki, et al.
Publicado: (2023)

Association analysis of non-synonymous polymorphisms of interleukin-4 receptor-α and interleukin-13 genes in canine atopic dermatitis
por: TANAKA, Kazuaki, et al.
Publicado: (2020)

An Interleukin-4 and Interleukin-13 Induced Atopic Dermatitis Human Skin Equivalent Model by a Skin-On-A-Chip
por: Kim, Kyunghee, et al.
Publicado: (2022)

Emerging Systemic Treatments for Atopic Dermatitis
por: Ferrucci, Silvia Mariel, et al.
Publicado: (2023)

Topical tacrolimus as treatment of atopic dermatitis
por: Furue, Masutaka, et al.
Publicado: (2009)

Treatment of Atopic Dermatitis with Biologic Drugs
por: Fabbrocini, Gabriella, et al.
Publicado: (2018)

Tolerability of Topical Treatments for Atopic Dermatitis
por: Draelos, Zoe D., et al.
Publicado: (2019)

From Emollients to Biologicals: Targeting Atopic Dermatitis
por: Salvati, Lorenzo, et al.
Publicado: (2021)

New Biologics for the Treatment of Atopic Dermatitis: Analysis of Efficacy, Safety, and Paradoxical Atopic Dermatitis Acceleration
por: Qi, Hong-jiao, et al.
Publicado: (2021)

Treatments for atopic dermatitis
por: Ross, Gayle
Publicado: (2023)

Skin Barrier and Inflammation Genes Associated with Atopic Dermatitis are Regulated by Interleukin-13 and Modulated by Tralokinumab In vitro
por: TOLLENAERE, Maxim A. X., et al.
Publicado: (2021)

Atopic dermatitis in adolescence
por: Ricci, Giampaolo, et al.
Publicado: (2011)

Psoriasis and Atopic Dermatitis
por: Griffiths, Christopher E. M., et al.
Publicado: (2017)

Microbiome in atopic dermatitis
por: Wollina, Uwe
Publicado: (2017)

The exposome in atopic dermatitis
por: Stefanovic, Nicholas, et al.
Publicado: (2019)

Emerging Nanomedicines for the Treatment of Atopic Dermatitis
por: Parekh, Khushali, et al.
Publicado: (2021)

Systematic Review on the Efficacy and Safety of Oral Janus Kinase Inhibitors for the Treatment of Atopic Dermatitis
por: Le, Michelle, et al.
Publicado: (2021)

Virus-Like Particle-Mediated Vaccination against Interleukin-13 May Harbour General Anti-Allergic Potential beyond Atopic Dermatitis
por: Foerster, John, et al.
Publicado: (2020)

Atopic dermatitis and atopic march: which link?
por: Maiello, Nunzia, et al.
Publicado: (2021)

New and emerging trends in the treatment of atopic dermatitis
por: Gelbard, Christina M, et al.
Publicado: (2008)

Treatment-resistant atopic dermatitis: challenges and solutions
por: Johnson, Brian B, et al.
Publicado: (2019)

Therapeutic Potential of Lebrikizumab in the Treatment of Atopic Dermatitis
por: Loh, Tiffany Y, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bfr92to29jh1q04mamrsso1gio